High intensity ultrasound ablation of canine prostate

Prostatic cancer is the most frequent malignant disease in man and without any satisfactory treatment of localized tumor in patients older than 70. Consequently, new therapeutic options are urgently needed to extend to unqualified patients, the potential benefits of surgery. These new options should ideally be non invasive and capable of extracorporeal and selective destruction of tissue. High intensity ultrasound is a good candidate for this new therapeutic option as it is known to induce tissue lesions in vivo by sharply focusing its beam on a specific target area within tissue [1-2].